Article
News briefing: Novo eyes the next kinases in a Finnish startup; Boehringer Ingelheim brings a bispe
Rating:
0.0
Views:
103
Likes:
1
Library:
1
Novo Seeds' Jeroen Bakker thinks he's found the next kinases. The early stage, European VC firm announced yesterday they led a $9 million seed round for Rappta Therapeutics, a Finnish biotech developing inhibitors for an enzyme called PP2A — protein phosphatase 2 — that Bakker thinks now hold the same
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value